However, in December 2004 the United States the 14-member Food and Drug Administration (FDA) advisory committee, plus voting consultants, for Reproductive Health Drugs unanimously rejected Procter and Gamble's fast-track request for Intrinsa citing concerns about off-label use . In Canada, post-menopausal women have been able to obtain government-approved testosterone treatment since 2002. In Australia, post-menopausal women can use Organon testosterone implants which have to be surgically inserted and last from three to six months. 
However, the Anavar steroid was discontinued by Searle in 1989, due to the bad press brought on by bodybuilders abusing the drug. It was later reintroduced to the world market as Oxandrin in 1995, but it remains a controlled substance under US law. The current manufacturer of oxandrolone holds all the rights to their medicine, and that’s why it is very rare to find oxandrolone today. It’s still called Anavar by most people, and it’s very hard to buy. Even if you do find Anavar for sale, the law of supply and demand inevitably results in a rather exorbitant price for the steroid.